CELLULAR BIOMEDICINE GROUP, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01 Regulation FD Disclosure.

Attached as Exhibit 99.1 to this Current Report is the form of presentation that Cellular Biomedicine Group, Inc. intends to use in connection with a virtual presentation to be held at 10:10 AM Eastern Standard Time on Sunday, August 30, 2020 at the 25th Annual Conference of the Chinese Biopharmaceutical Association-USA. Attached as Exhibit 99.2 to this Current Report is the Press Release for the presentation.

The foregoing (including Exhibit 99.1 and Exhibit 99.2) is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01. Financial Statements and Exhibits.

(d)      Exhibits

99.1   Presentation, dated August 30, 2020

99.2   Press Release, dated August 26, 2020

104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

© Edgar Online, source Glimpses